Study Summary
This trial studies how an app can help people learn about, think about, and act on COVID-19 self-testing.
- COVID-19, Thalidomide Syndrome
- Coronavirus
- COVID-19
- Coronavirus Disease 2019 (COVID-19)
- Long-haul COVID-19
- Mild-to-Moderate COVID-19
- COVID-19 (coronavirus disease 2019)
Treatment Effectiveness
Phase-Based Effectiveness
Study Objectives
1 Primary · 0 Secondary · Reporting Duration: At study completion (~ 1 month after enrollment)
Trial Safety
Phase-Based Safety
Awards & Highlights
Trial Design
2 Treatment Groups
Control (No App) Group
1 of 2
Intervention (App) Group
1 of 2
Active Control
Experimental Treatment
100 Total Participants · 2 Treatment Groups
Primary Treatment: Intervention (App) Group · No Placebo Group · N/A
Trial Logistics
Trial Timeline
Who is running the clinical trial?
Eligibility Criteria
Age 18+ · All Participants · 3 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:Who else is applying?
What state do they live in?
| California | 100.0% |
What site did they apply to?
| ICAP Harlem Prevention Center | 100.0% |
What portion of applicants met pre-screening criteria?
| Met criteria | 100.0% |
Frequently Asked Questions
Are there any available slots for participants in this research project?
"As noted on clinicaltrials.gov, this research programme is actively recruiting participants for the trial which was published in January of 2021 and most recently revised at the end of that same month." - Anonymous Online Contributor
How many participants are currently involved in this experiment?
"Indeed, clinicaltrials.gov reveals that the trial is currently welcoming patients. This study was initially publicized on January 1st 2023 and was most recently updated on 25th of the same month. It requires 100 volunteers from a solitary location to participate in this research project." - Anonymous Online Contributor